ArticleCancer communications (London, England)2025

Targeted reactivation of the novel tumor suppressor DAPK1, an upstream regulator of p53, in high-grade serous ovarian cancer by mRNA liposomes reduces viability and enhances drug sensitivity in preclinical models.

Monika Raab et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.